Market Trends of Johne's Disease Diagnostics Industry
This section covers the major market trends shaping the Johne's Disease Diagnostics Market according to our research experts:
The Cattle Segment is Expected to Witness Growth Over the Forecast Period.
The cattle segment is expected to witness significant growth in the Johne's disease diagnostics market over the forecast period. The cattle segment includes cows, bulls, oxen, calves, and buffaloes. Increased zoonotic disease incidence in cattle is likely to drive vertebral expansion.
Furthermore, continuous new product developments in Johne's disease diagnostics launched by major players in the market are positively affecting the growth of the segment. A New Zealand biotech company, for example, will release a multiplexed diagnostic test for John's disease in June 2022.It makes it possible to track complicated diseases through several stages of infection by using biomarkers that are present at different points in the infection cycle, including asymptomatic stages. This is different from traditional Elisa, which only detects a disease at a single point in time.
The segmental growth is also attributable to rising supportive initiatives and eradication programs. For instance, the Irish Johne's Control Programme (IJCP) is a long-term voluntary control program for Johne's disease (JD) in Ireland, with strong support from the Irish cattle industry. It takes advantage of the formation of Animal Health Ireland to combat animal diseases not covered by EU regulations. Furthermore, it has four goals: prevent the transmission of JD to uninfected farms, reduce the degree of infection when it exists, ensure JD control markets in Ireland, and promote calf health and farm biosecurity. Therefore, the cattle segment is expected to witness significant growth over the forecast period due to the above-mentioned factors.
North America is Expected to Dominate the Johne's Disease Diagnostics Market
Over the next few years, North America is expected to be the biggest market for Johne's disease diagnostics. This is because of things like the growing Johne's disease eradication effort, the growing animal population, spending, and the presence of key players.
The regional market for Johne's disease diagnostics is now being supported by constant innovation in the veterinary diagnostics sector. For instance, in July 2020, VMRD obtained USDA approval for the testing of goat serum on their John's antibody test kit. This is a new thing that comes on top of the USDA license for bovine serum and milk samples, for which this test is already used in U.S. labs.
Moreover, the large market share of the region in the Johne's disease diagnostics market can be attributed to the local presence of major players, such as Thermo Fisher Scientific, Inc., Zoetis, and IDEXX, which are involved in the development and introduction of tests required for the diagnosis of Johne's disease. Collaborations between local and international companies and acquisitions are also expected to fuel market growth in the region. For instance, in April 2020, Zoetis completed the acquisition of Performance Livestock Analytics to improve its animal health solutions across the continuum of care for beef producers. Because of these factors, it is likely that the studied market will grow in the North American region.
